Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Morin

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Plos Pathogens|September 24, 2010
The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcriptionBenjamin Morin, Bruno Coutard, Michaela Lelke, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2011
Adaptive human behavior in epidemiological modelsEli P Fenichel, Carlos Castillo-Chavez, M G Ceddia, et al.
Ecohealth|September 20, 2014
Merging economics and epidemiology to improve the prediction and management of infectious diseaseCharles Perrings, Carlos Castillo-Chavez, Gerardo Chowell, et al.
Cancer Cell|June 13, 2018
Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell AntigensJeremy D Waight, Dhan Chand, Sylvia Dietrich, et al.
Nature Communications|June 23, 2023
Molecular mechanism of phosphopeptide neoantigen immunogenicityYury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2026
Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II TrialHaitham Mirghani, Anne Aupérin, Caroline Even, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2026
HPV16 genomic status stratifies risk of disease recurrence in oropharyngeal squamous cell carcinomaVictor Malassigné, Julien Puech, Sandrine Imbeaud, et al.
Plos One|April 5, 2018
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibodyRandi B Gombos, Ana Gonzalez, Mariana Manrique, et al.
Cancer Discovery|July 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional ImmunotherapyDhan Chand, David A Savitsky, Shanmugarajan Krishnan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Plos Pathogens|September 24, 2010
The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcriptionBenjamin Morin, Bruno Coutard, Michaela Lelke, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2011
Adaptive human behavior in epidemiological modelsEli P Fenichel, Carlos Castillo-Chavez, M G Ceddia, et al.
Ecohealth|September 20, 2014
Merging economics and epidemiology to improve the prediction and management of infectious diseaseCharles Perrings, Carlos Castillo-Chavez, Gerardo Chowell, et al.
Cancer Cell|June 13, 2018
Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell AntigensJeremy D Waight, Dhan Chand, Sylvia Dietrich, et al.
Nature Communications|June 23, 2023
Molecular mechanism of phosphopeptide neoantigen immunogenicityYury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2026
Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II TrialHaitham Mirghani, Anne Aupérin, Caroline Even, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2026
HPV16 genomic status stratifies risk of disease recurrence in oropharyngeal squamous cell carcinomaVictor Malassigné, Julien Puech, Sandrine Imbeaud, et al.
Plos One|April 5, 2018
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibodyRandi B Gombos, Ana Gonzalez, Mariana Manrique, et al.
Cancer Discovery|July 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional ImmunotherapyDhan Chand, David A Savitsky, Shanmugarajan Krishnan, et al.
Pageof 3